Shapely Tirzepatide Review: Cost, a Harvard-Trained Founder & Honest Verdict (2026)

Shapely: founded by Dr. Justin Zaghi, MD/MBA — Harvard-trained and board-certified in both internal medicine and obesity medicine — with a named Medical Director, offering genuinely bundled 1:1 dietitian access, though available in only 4 states. Every fact here comes from the company's own published program.

What Shapely is

Shapely is a GLP-1 telehealth platform, founded by Dr. Justin Zaghi, MD/MBA, with named Medical Director Ana Lisa. Brand-name GLP-1s — Wegovy, Ozempic, Zepbound, Mounjaro, and Foundayo — are covered by major PPO and Medicare plans at copay, a genuinely strong insurance pathway most competitors don't offer.

What Shapely costs

Compounded semaglutide starts from $99/month, with a separate telehealth subscription ($99/month self-pay, $49 first-month promo) charged apart from the medication cost. A cellular smart scale is provided to qualifying patients for ongoing weight tracking, and 1:1 registered dietitian access plus monthly video provider visits are included in every plan.

The brand-vs-compounded question

Shapely offers both compounded and brand-name options, with the brand pathway genuinely covered by major insurance. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials; the brand option is the exact molecule and dose that was. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Shapely's real strengths is a named, highly credentialed physician founder, genuine insurance coverage for brand-name GLP-1s at copay, bundled 1:1 dietitian access and monthly video visits, free 2-day shipping with syringes and supplies, and a cellular smart scale for qualifying patients. The trade-offs: it's available in only 4 states (California, Florida, New York, Texas) despite announced expansion, the telehealth subscription is billed separately from medication cost, labs aren't included — a $75 flat fee applies for uninsured patients, no LegitScript certification is found on any public page, and the compounding pharmacy isn't named publicly. As with any GLP-1 program, confirm your state is among the 4 currently served; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Shapely's Harvard-trained physician founder, genuine insurance coverage for brand-name drugs, and bundled dietitian access are real strengths, but its 4-state footprint is a significant limit for most patients. For a similarly credentialed, dietitian-supported provider with broader coverage, compare it against Signos or CoreAge Rx. See our best tirzepatide providers ranking for the full field.